Qualigen Therapeutics Inc. Price to FCF Ratio 2015–2026

PE Ratio PS Ratio Price to Book Price to FCF Net Worth

Price to free cash flow (P/FCF) ratio for Qualigen Therapeutics Inc. (AIXC): market cap divided by trailing twelve-month free cash flow. As of September 30, 2021 it is 375386.64.

From: 06/30/2020To: 06/30/2023

Stock Price

TTM Free Cash Flow

Price to FCF

Qualigen Therapeutics Inc. Price to FCF Ratio — FAQ

Qualigen Therapeutics Inc. (AIXC) price to fcf ratio over the last 4 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see AIXC's price to fcf ratio history?

The chart and table above show Qualigen Therapeutics Inc.'s price to fcf ratio by year and by quarter, including the growth rate.